Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial (Q42279908)
Jump to navigation
Jump to search
scientific article published on 7 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial |
scientific article published on 7 January 2013 |
Statements
1 reference
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial (English)
1 reference
Staffan Nilsson
1 reference
Anders Blaxhult
1 reference
Magnus Gisslén
1 reference
Leo Flamholc
1 reference
Lars-Magnus Andersson
1 reference
Jan Vesterbacka
1 reference
Vidar Ormaasen
1 reference
Anders Sönnerborg
1 reference
7 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference